Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Modular Medical ( (MODD) ) is now available.
On May 28, 2025, Modular Medical announced the appointment of Jeff Goldberg to its Board of Directors. Goldberg, an industry veteran with extensive experience in healthcare and medical devices, is expected to play a key role in advancing Modular Medical’s mission to simplify insulin delivery and enhance diabetes care. His previous work includes significant achievements in launching generic insulin products and guiding early-stage technologies to commercial success, aligning with Modular Medical’s focus on innovation and affordability.
The most recent analyst rating on (MODD) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Modular Medical stock, see the MODD Stock Forecast page.
More about Modular Medical
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company focused on launching innovative insulin delivery technology. The company aims to make insulin delivery both affordable and simple, improving access to high-quality glycemic control for a broader range of diabetes patients. Founded by Paul DiPerna, Modular Medical leverages patented technologies to eliminate the complexity-efficacy tradeoff in insulin delivery.
Average Trading Volume: 117,178
Technical Sentiment Signal: Sell
Current Market Cap: $47.47M
See more data about MODD stock on TipRanks’ Stock Analysis page.